Home » Topics » BioWorld Science

BioWorld Science
RSS

Centrin-knockout L. mexicana show immunization promise for New World cutaneous leishmaniasis

March 31, 2022

ANDY mouse mimics age-dependent NAD decline and its metabolic impact

March 31, 2022

New NLRP3 inflammasome inhibitors identified at NodThera

March 31, 2022

New STAT5 inhibitors synthesized at Janpix

March 31, 2022

The University of Southern California patents Huntingtin aggregation inhibitors

March 31, 2022

Orexia Therapeutics discovers orexin OX2 receptor agonists

March 31, 2022

New STING agonists identified at The Scripps Research Institute

March 31, 2022

Adenosine A2B receptor targeting protects against acetaminophen-induced hepatotoxicity

March 31, 2022

Researchers present new Slc39a14-knockout dystonia murine model

March 30, 2022

Protein is marker, target for diabetic neuropathy

March 30, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...